Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

PACS Group (PACS) Faces Securities Class Action - Hagens Berman

SAN FRANCISCO - (NewMediaWire) - November 15, 2024 - PACS Group, Inc. (NYSE: PACS) and certain of its key executives have been named as defendants in a securities class action brought on behalf of PACS investors alleging violations of the U.S. securities laws.

 

Hagens Berman has begun an investigation into the matter and urges investors in PACS Group who purchased shares pursuant to PACS’ April 2024 IPO or on the post-IPO open market and suffered substantial losses to submit your losses now.

 

Class Period: Apr. 11, 2024 - Nov. 5, 2024

Lead Plaintiff Deadline: Jan. 13, 2025

Visit: www.hbsslaw.com/investor-fraud/pacs

Contact the Firm Now:

PACS@hbsslaw.com

844-916-0895

 

PACS Group (PACS) Securities Class Action:

The complaint alleges that, in the IPO offering documents and throughout the Class Period, PACS and additional defendants made false and misleading statements and failed to disclose that PACS engaged in schemes to: (1) submit false Medicare claims; (2) bill thousands of unnecessary respiratory and sensory integration therapies to Medicare; and (3) falsify documentation related to licensure and staffing.

The lawsuit follows Hindenburg’s Nov. 4, 2024 report, which was the product of an investigation that spanned five months and involved interviews with numerous former employees and competitors, concluded that PACS’s business model relies heavily on exploiting taxpayer-funded healthcare programs. The famed analyst alleges that the company:  

·       Abused a COVID-era waiver to inappropriately access Medicare benefits for thousands of patients.

·       Falsified patient records to inflate revenue and earnings.

·       Engaged in fraudulent licensing practices to circumvent regulatory oversight.

On the news of the Hindenburg report, the price of PACS Group shares plunged $11.93, or over 27% lower.

Then, on Nov. 6, 2024, PACS revealed that it received civil investigative demands from the federal government “regarding the Company’s reimbursement and referral practices that may or may not relate to this week’s third-party report.” PACS also announced the postponement of its Q3 2024 financial results.

This news drove the price of PACS shares crashing $11.45, or over 38% lower, to close at $18.09 (well below the $21 IPO price).

In response to the allegations, law firm Hagens Berman has initiated an investigation into PACS Group’s business practices and disclosures. The firm is seeking to represent investors who may have suffered significant losses due to the company's alleged misconduct.

“We’re focused on whether PACS may have misled investors and regulators about its business practices and purported value-creation strategies,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in PACS Group or have knowledge that may assist the firm’s investigation, submit your losses now

If you’d like more information and answers to frequently asked questions about the PACS case and our investigation, read more

Whistleblowers: Persons with non-public information regarding PACS Group should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email PACS@hbsslaw.com.

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:
Reed Kathrein, 844-916-0895

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.